Dr Natasa Dragicevic is a fellowship trained behavioral neurologist with a PhD in Neurobiology and strong background in basic science. She completed her subspecialty training at Columbia University New York Presbyterian Hospital and New York Neurological Institute, where she became interested in mitochondrial dysfunction and its impact on cognitive function. Her area of expertise as neurodegenerative diseases including Alzeimer’s disease, frontotemporal dementia, Dementia with Lewy bodies as well as mitochondrial diseases and autoimmune encephalitides. She is currently Assistant Professor of Neurology and Director of Behavioral Neurology at University of Connecticut Medical center.
Title : Evaluation of short term treatment with NAD+ precursor Nicotinamide Riboside on cognitive and mitochondrial function in patients with MELAS